Search

Author/Creator Ohsumi, Shozo

1. Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer. (28th May 2020)

Authors:
Ohsumi, Shozo; Mukai, Hirofumi; Takahashi, Masato; Hozumi, Yasuo; Akabane, Hiromitsu; Park, Youngjin; Tokunaga, Eriko; Takashima, Tsutomu; Watanabe, Takanori; Sagara, Yoshiaki; Kaneko, Tetsuji; Ohashi, Yasuo
Journal:
Japanese journal of clinical oncology
Issue:
Volume 50:Number 8(2020)
Page Start:
873
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers. (7th November 2022)

Authors:
Mori, Tomoharu; Okamoto, Yusuke; Mu, Anfeng; Ide, Yoshimi; Yoshimura, Akiyo; Senda, Noriko; Inagaki‐Kawata, Yukiko; Kawashima, Masahiro; Kitao, Hiroyuki; Tokunaga, Eriko; Miyoshi, Yasuo; Ohsumi, Shozo; Tsugawa, Koichiro; Ohta, Tomohiko; Katagiri, Toyomasa; Ohtsuru, Shigeru; Koike, Kaoru; Ogawa, S...
Journal:
Cancer medicine
Issue:
Volume 12:Number 6(2023)
Page Start:
6594
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Risk factors for locoregional disease recurrence after breast‐conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta‐analysis. Issue 14 (3rd May 2018)

Authors:
Valachis, Antonios; Mamounas, Eleftherios P.; Mittendorf, Elizabeth A.; Hayashi, Naoki; Ishitobi, Makoto; Natoli, Clara; Fitzal, Florian; Rubio, Isabel T.; Tiezzi, Daniel G.; Shin, Hee‐Chul; Anderson, Stewart J.; Hunt, Kelly K.; Matsuda, Naoko; Ohsumi, Shozo; Totomi, Athina; Nilsson, Cecilia
Journal:
Cancer
Issue:
Volume 124:Issue 14(2018)
Page Start:
2923
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031). (25th June 2022)

Authors:
Saji, Shigehira; Ohsumi, Shozo; Ito, Mitsuya; Hayashi, Naoki; Kobayashi, Kokoro; Masuda, Norikazu; Niikura, Naoki; Yamashita, Toshinari; Kiyama, Keiichiro; Hasegawa, Ayumi; Nakagawa, Shizuka; Hattori, Masaya
Journal:
Japanese journal of clinical oncology
Issue:
Volume 52:Number 10(2022)
Page Start:
1124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗